drugset / Trial / NCT00800332

Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy

NCT00800332 ↗

Phase 2 Completed 300 enrolled Cytos Biotechnology AG
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to test whether vaccinations with CYT003-QbG10 can improve allergy symptoms in patients with house dust mite allergy. The active treatment will be compared against placebo.

Timeline

Start
2008-11
Primary completion
2010-04
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject CYT003-QbG10 Vaccine — Subcutaneous

Indications